|
|
|
Fiscal Period: December
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Capitalization1 |
207 263 | 267 779 | 264 244 | 310 274 | - | - |
| Entreprise Value (EV)1 |
212 915 | 270 284 | 266 126 | 305 889 | 300 145 | 290 729 |
| P/E ratio |
19,9x | 20,1x | 18,7x | 19,5x | 18,8x | 17,0x |
| Yield |
3,57% | 2,87% | 2,94% | 2,60% | 2,69% | 2,80% |
| Capitalization / Revenue |
3,65x | 4,36x | 4,53x | 4,99x | 4,97x | 4,76x |
| EV / Revenue |
3,75x | 4,40x | 4,56x | 4,92x | 4,81x | 4,46x |
| EV / EBITDA |
9,33x | 10,6x | 11,0x | 12,0x | 11,6x | 10,6x |
| Price to Book |
7,58x | 8,28x | 7,27x | 6,75x | 6,08x | 5,26x |
| Nbr of stocks (in thousands) |
854 163 | 856 061 | 854 642 | 854 261 | - | - |
| Reference price (CHF) |
243 | 314 | 309 | 359 | 359 | 359 |
| Announcement Date |
01/31/2019 | 01/30/2020 | 02/04/2021 | - | - | - |
1 CHF in Million |
|
|
| Income Statement Evolution (Annual data) |
|
|
Fiscal Period: December
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Net sales1 |
56 846 | 61 466 | 58 323 | 62 134 | 62 457 | 65 247 |
| EBITDA1 |
22 825 | 25 419 | 24 281 | 25 589 | 25 860 | 27 367 |
| Operating profit (EBIT)1 |
20 505 | 22 479 | 21 536 | 22 850 | 23 276 | 24 855 |
| Operating Margin |
36,1% | 36,6% | 36,9% | 36,8% | 37,3% | 38,1% |
| Pre-Tax Profit (EBT)1 |
14 148 | 16 614 | 17 965 | 19 940 | 20 764 | 22 677 |
| Net income1 |
10 500 | 13 497 | 14 295 | 15 285 | 15 706 | 17 299 |
| Net margin |
18,5% | 22,0% | 24,5% | 24,6% | 25,1% | 26,5% |
| EPS2 |
12,2 | 15,6 | 16,5 | 18,4 | 19,1 | 21,1 |
| Dividend per Share2 |
8,70 | 9,00 | 9,10 | 9,33 | 9,64 | 10,1 |
| Announcement Date |
01/31/2019 | 01/30/2020 | 02/04/2021 | - | - | - |
1 CHF in Million 2 CHF |
|
|
| Income Statement Evolution (Quarterly data) |
|
|
Fiscal Period: December
|
2016 S2 |
2017 S1 |
2017 S2 |
2018 S1 |
2018 S2 |
2019 Q1 |
2019 Q2 |
2019 S1 |
2019 Q3 |
2019 Q4 |
2019 S2 |
2020 Q1 |
2020 Q2 |
2020 S1 |
2020 Q3 |
2020 Q4 |
2020 S2 |
2021 Q1 |
2021 Q2 |
2021 S1 |
2021 Q3 |
2021 Q4 |
2021 S2 |
2022 Q1 |
2022 Q2 |
2022 S1 |
2022 Q3 |
2022 S2 |
| Net sales1 |
26 000 | 26 344 | 26 955 | 28 111 | 28 735 | 14 826 | 15 643 | 30 469 | 15 597 | 15 400 | 30 997 | 15 143 | 14 138 | 29 281 | 14 698 | 14 344 | 29 042 | 14 930 | 15 783 | 30 713 | 15 787 | 15 425 | 31 567 | 15 450 | 15 630 | 31 080 | 15 800 | 31 900 |
| EBITDA |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating profit (EBIT) |
8 570 | 10 135 | 8 877 | 11 162 | 9 343 | - | - | 12 363 | - | - | 10 116 | - | - | 11 766 | - | - | 9 770 | - | - | 11 652 | - | - | 11 399 | - | - | - | - | - |
| Operating Margin |
33,0% | 38,5% | 32,9% | 39,7% | 32,5% | - | - | 40,6% | - | - | 32,6% | - | - | 40,2% | - | - | 33,6% | - | - | 37,9% | - | - | 36,1% | - | - | - | - | - |
| Pre-Tax Profit (EBT) |
- | - | - | - | 4 654 | - | - | 10 354 | - | - | 6 260 | - | - | 10 181 | - | - | 7 784 | - | - | 9 887 | - | - | - | - | - | - | - | - |
| Net income |
- | 5 477 | - | - | 3 191 | - | - | 8 619 | - | - | 4 878 | - | - | 8 079 | - | - | 6 216 | - | - | 7 803 | - | - | - | - | - | - | - | - |
| Net margin |
- | 20,8% | - | - | 11,1% | - | - | 28,3% | - | - | 15,7% | - | - | 27,6% | - | - | 21,4% | - | - | 25,4% | - | - | - | - | - | - | - | - |
| EPS |
4,89 | 6,37 | 3,67 | 8,51 | 3,70 | - | - | 9,99 | - | - | 5,63 | - | - | 9,32 | - | - | 7,20 | - | - | 9,05 | - | - | - | - | - | - | - | - |
| Dividend per Share |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date |
02/01/2017 | 07/27/2017 | 02/01/2018 | 07/26/2018 | 01/31/2019 | 04/17/2019 | 07/25/2019 | 07/25/2019 | 10/16/2019 | 01/30/2020 | 01/30/2020 | 04/22/2020 | 07/23/2020 | 07/23/2020 | 10/15/2020 | 02/04/2021 | 02/04/2021 | 04/21/2021 | 07/22/2021 | 07/22/2021 | - | - | - | - | - | - | - | - |
1 CHF in Million |
|
|
|
|
|
Fiscal Period: December
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Net Debt1 |
5 652 | 2 505 | 1 882 | - | - | - |
| Net Cash position1 |
- | - | - | 4 385 | 10 129 | 19 545 |
| Leverage (Debt / EBITDA) |
0,25x | 0,10x | 0,08x | -0,17x | -0,39x | -0,71x |
| Free Cash Flow1 |
14 811 | 16 764 | 10 943 | 15 444 | 16 887 | 17 392 |
| ROE (Net Profit / Equities) |
57,7% | 57,7% | 48,0% | 41,5% | 36,4% | 34,3% |
| Shareholders' equity1 |
18 202 | 23 392 | 29 789 | 36 810 | 43 096 | 50 395 |
| ROA (Net Profit / Asset) |
20,1% | 21,6% | 19,6% | 18,5% | 17,3% | 16,6% |
| Assets1 |
52 252 | 62 621 | 72 966 | 82 686 | 90 747 | 103 909 |
| Book Value Per Share2 |
32,1 | 37,9 | 42,5 | 53,1 | 59,0 | 68,2 |
| Cash Flow per Share2 |
23,2 | 25,9 | 21,5 | 22,8 | 23,5 | 25,0 |
| Capex1 |
4 043 | 3 503 | 3 528 | 3 703 | 3 775 | 3 933 |
| Capex / Sales |
7,11% | 5,70% | 6,05% | 5,96% | 6,04% | 6,03% |
| Announcement Date |
01/31/2019 | 01/30/2020 | 02/04/2021 | - | - | - |
1 CHF in Million 2 CHF |
|
|
|
|
|
Roche shareholders approve deal to buy Novartis's $20.7 billion stake |
| Capitalization (CHF) |
310 273 959 815 |
| Capitalization (USD) |
336 161 778 367 |
| Net sales (CHF) |
58 323 000 000 |
| Net sales (USD) |
63 023 250 570 |
| Number of employees |
101 465 |
| Sales / Employee (CHF) |
574 809 |
| Sales / Employee (USD) |
621 133 |
| Free-Float |
83,5% |
| Free-Float capitalization (CHF) |
259 203 248 194 |
| Free-Float capitalization (USD) |
280 829 963 699 |
| Avg. Exchange 20 sessions (CHF) |
377 475 021 |
| Avg. Exchange 20 sessions (USD) |
407 895 733 |
| Average Daily Capital Traded |
0,12% |
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous period
